Table 5 POAG prevalence by age and sex, 2010, AOK data
| Â | Age | Prevalence (%), 95%-CI (Binomial Exact) | Prevalent persons | Persons on 01.01.2010 | ||
|---|---|---|---|---|---|---|
Males | 50–54 | 0.84 | (0.74–0.95)1 | 252 | 8.0% | 29,949 |
55–59 | 1.38 | (1.21–1.57) | 227 | 7.2% | 16,418 | |
60–64 | 2.07 | (1.83–2.33) | 271 | 8.7% | 13,090 | |
65–69 | 3.27 | (2.99–3.57) | 473 | 15.1% | 14,465 | |
70–74 | 4.44 | (4.13–4.77) | 715 | 22.8% | 16,102 | |
75–79 | 5.32 | (4.90–5.76) | 562 | 17.9% | 10,568 | |
80–84 | 6.06 | (5.49–6.66) | 400 | 12.8% | 6605 | |
85–89 | 6.91 | (5.98–7.93) | 186 | 5.9% | 2693 | |
90+ | 5.89 | (4.34–7.78) | 46 | 1.5% | 781 | |
Total | 3132 | 110,671 | ||||
Females | 50–54 | 0.84 | (0.73–0.95) | 242 | 4.8% | 28,932 |
55–59 | 1.58 | (1.39–1.78) | 264 | 5.2% | 16,739 | |
60–64 | 2.47 | (2.21–2.74) | 334 | 6.6% | 13,538 | |
65–69 | 3.83 | (3.54–4.14) | 614 | 12.2% | 16,042 | |
70–74 | 5.02 | (4.72–5.33) | 1007 | 20.0% | 20,070 | |
75–79 | 6.15 | (5.80–6.52) | 1043 | 20.7% | 16,953 | |
80–84 | 6.25 | (5.85–6.66) | 860 | 17.1% | 13,770 | |
85–89 | 5.49 | (5.03–5.97) | 510 | 10.1% | 9296 | |
90+ | 4.04 | (3.45–4.69) | 161 | 3.2% | 3989 | |
Total | 5035 | 139,329 | ||||
Total | 50–54 | 0.84 | (0.77–0.92) | 494 | 6.0% | 58,881 |
55–59 | 1.48 | (1.35–1.62) | 491 | 6.0% | 33,157 | |
60–64 | 2.27 | (2.10–2.46) | 605 | 7.4% | 26,628 | |
65–69 | 3.56 | (3.36–3.78) | 1087 | 13.3% | 30,507 | |
70–74 | 4.76 | (4.54–4.99) | 1722 | 21.1% | 36,172 | |
75–79 | 5.83 | (5.56–6.12) | 1605 | 19.7% | 27,521 | |
80–84 | 6.18 | (5.86–6.52) | 1260 | 15.4% | 20,375 | |
85–89 | 5.81 | (5.39–6.24) | 696 | 8.5% | 11,989 | |
90+ | 4.34 | (3.78–4.96) | 207 | 2.5% | 4770 | |
Total | 8167 | 250,000 | ||||